Concourse Financial Group Securities, Inc. Rani Therapeutics Holdings, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $0
- Q1 2025
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
100.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding RANI
# of Institutions
44Shares Held
3.47MCall Options Held
44.3KPut Options Held
111K-
Vanguard Group Inc Valley Forge, PA800KShares$407,8360.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$251,7270.6% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$228,7300.05% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$154,3980.01% of portfolio
-
Geode Capital Management, LLC Boston, MA196KShares$100,0700.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $12.5M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...